Your browser doesn't support javascript.
loading
Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.
Rohner, Eliane; Edelman, Claire; Sanusi, Busola; Schmitt, John W; Baker, Anna; Chesko, Kirsty; Faherty, Brian; Gregory, Sean M; Romocki, LaHoma S; Sivaraman, Vijay; Nelson, Julie A E; O'Connor, Siobhan; Hudgens, Michael G; Knittel, Andrea K; Rahangdale, Lisa; Smith, Jennifer S.
Afiliação
  • Rohner E; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Edelman C; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
  • Sanusi B; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Schmitt JW; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
  • Baker A; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Chesko K; Becton, Dickinson and Company, Sparks, Maryland.
  • Faherty B; Becton, Dickinson and Company, Sparks, Maryland.
  • Gregory SM; Becton, Dickinson and Company, Sparks, Maryland.
  • Romocki LS; Department of Public Health Education, North Carolina Central University, Durham, North Carolina.
  • Sivaraman V; Department of Biological and Biomedical Sciences, North Carolina Central University, Durham, North Carolina.
  • Nelson JAE; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • O'Connor S; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Hudgens MG; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Knittel AK; Department of Obstetrics & Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Rahangdale L; Department of Obstetrics & Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Smith JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Cancer Epidemiol Biomarkers Prev ; 29(12): 2651-2661, 2020 12.
Article em En | MEDLINE | ID: mdl-32943435
ABSTRACT

BACKGROUND:

Primary high-risk human papillomavirus (hr-HPV) testing of self-collected cervico-vaginal swabs could increase cervical cancer screening coverage, although triage strategies are needed to reduce unnecessary colposcopies. We evaluated the use of extended hr-HPV genotyping of self-collected samples for cervical cancer screening.

METHODS:

We recruited women ages 25-65 years at two colposcopy clinics in North Carolina between November 2016 and January 2019, and obtained self-collected cervico-vaginal samples, provider-collected cervical samples, and cervical biopsies from all enrolled women. Self- and provider-collected samples were tested for 14 hr-HPV genotypes using the Onclarity Assay (Becton Dickinson). We calculated hr-HPV genotype-specific prevalence and assessed agreement between results in self- and provider-collected samples. We ranked the hr-HPV genotypes according to their positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or higher (CIN2+).

RESULTS:

A total of 314 women participated (median age, 36 years); 85 women (27%) had CIN2+. More women tested positive for any hr-HPV on self-collected (76%) than on provider-collected samples (70%; P = 0.009) with type-specific agreement ranging from substantial to almost perfect. HPV-16 was the most common genotype in self-collected (27%) and provider-collected samples (20%), and HPV-16 prevalence was higher in self- than provider-collected samples (P < 0.001). In self- and provider-collected samples, HPV-16 had the highest PPV for CIN2+ detection.

CONCLUSIONS:

Overall sensitivity for CIN2+ detection was similar for both sample types, but the higher HPV-16 prevalence in self-collected samples could result in increased colposcopy referral rates. IMPACT Additional molecular markers might be helpful to improve the triage of women who are hr-HPV positive on self-collected samples.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Papillomavirus Humano 16 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Papillomavirus Humano 16 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article